News

October 19, 2020 (BioTechniques) Matching cancer patients to the therapies that provide the best chance of overcoming their disease is a difficult process, leading to a gap between the wealth of [...]

Contributed Commentary By Jarret Glasscock October 14, 2020 (DiagnosticsWorld) It has been said that the most dangerous phrase in business is, “We’ve always done it this way”. Believing that the [...]

September 23, 2020 (OncologyCentral) Title: Panel discussion: the past, present and future of immuno-oncology Duration: 1 hour This panel discussion, featuring experts from institutions across [...]

Industry Challenge Using precision medicine, researchers aim to find a new diagnostic approach for matching cancer patients with treatments and therapies based on multidimensional RNA models of [...]

SAN DIEGO, Calif.– SEPTEMBER 15, 2020 (Reportable) – Physicians at the University of California, San Diego (UCSD) School of Medicine and Cofactor Genomics, the company bridging the precision [...]

SAN FRANCISCO, September 9, 2020 (MedCityNews) – MedCity Influencers, Biopharma News By harnessing the combined power of NGS, machine learning and the dynamic nature of RNA we’re able to [...]

SAN FRANCISCO, Calif. – August 20, 2020 (Reportable) – Cofactor Genomics, the company bridging the precision medicine gap, announced today that the United States Patent and Trademark Office [...]

SAN FRANCISCO, July 23, 2020 (ClinicalOMICs) – Jarret Glasscock, CEO of Cofactor Genomics, recently spoke with Patrick Hurban, Senior Director and Global Head, Translational Genomics at [...]

SAN FRANCISCO, July 2020 (PharmaTimes Magazine) – We’ve come a long way from the early days of using medicinal leeches and mercury treatments as therapeutics. As described in the book [...]

SAN FRANCISCO, July 9, 2020 (AWS Web Day) – Keeping the Focus on Patients.  Cofactor was recently featured in the AWS Healthcare and Life Sciences Web Day, with on-demand recordings now [...]